Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro- Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer

Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro- Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer

Objective(s): We performed a phase IIa clinical trial of trans-1-amino-3-18Ffluoro-cyclobutane carboxylic acid (anti-18F-FACBC), a synthetic amino acid analog for PET, in patients with metastatic prostate cancer. Methods: The study subjects consisted of 10 untreated prostate cancer patients having l...

Full description

Bibliographic Details
Main Authors: Yusuke Inoue, Yuji Asano, Takefumi Satoh, Ken-ichi Tabata, Kei Kikuchi, Reiko Woodhams, Shiro Baba, Kazushige Hayakawa
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2014-10-01
Series:Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:
Anti-18F-FACBC Metastasis Positron Emission Tomography Prostate cancer
Online Access:http://aojnmb.mums.ac.ir/pdf_2842_0c3f4ea3da06cd41a5a3b173602cc89a.html

Internet

http://aojnmb.mums.ac.ir/pdf_2842_0c3f4ea3da06cd41a5a3b173602cc89a.html

Similar Items